Comparative field study of Rapid-Antigen Detection (RAD) with Multiplex Real Time-PCR for COVID-19 diagnosis
DOI:
https://doi.org/10.54393/pbmj.v5i4.397Abstract
RT-PCR is a gold standard test for the diagnosis of SARS-CoV2 (Covid-19) infection; however, it is an expensive, time consuming and technical demanding technique. Rapid antigen detection immunoassay (RAD) is cost-effective, quick as well as can be performed and interpreted easily. The rapid diagnosis of COVID-19 patients is essential to reduce cost and control the disease spread; however, the real world data of these tests must be validated with RT-PCR before they can be used at large scale. The objective of this study was to determine the sensitivity and specificity of PanbioTMCOVID-19 Ag-Rapid test device (Abbot) with multiplex RT-PCR. METHODS: A total of n=3509 samples were tested for SARS-CoV-2 RAD and RT-PCR at Institute of Biomedical and Genetic Engineering, Islamabad. The rapid antigen tests were performed by PanbioTMCOVID-19 Ag-Rapid test device (Abbott) and compared with RT-PCR performed on Thermo Fisher (ABI) Quant Studio 5 using CDC 2019-nCoV RT-PCR protocol. RESULTS: Total (n=3509), n=458 (7.60%) samples were reported positive by rapid antigen out of which n= 445 RT-PCR positive (13 false positive by rapid antigen), n=3051 (92.4%) were negative. True antigen negative tests n= 3051) were repeated with RT-PCR among these, n=25 were observed RT-PCR positive (rapid antigen false negative). The threshold cycle (CT) for the RT-PCR tests of these samples was >30. CONCLUSION: PanbioTMCOVID-19 Ag-Rapid test devices (Abbott) showed a sensitivity ratio 94.6% compared to RT-PCR. The PanbioTMCOVID-19 Ag-Rapid test device (Abbott) is reliable and can be used for screening and isolation of positive patients from the population.
References
Su, S., et al., Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in microbiology, 2016. 24(6): p. 490-502.
https://doi.org/10.1016/j.tim.2016.03.003
WHO, C.O., World health organization. Responding to Community Spread of COVID-19. Reference WHO/COVID-19/Community_Transmission/2020.1, 2020.
Florez, H. and S. Singh, Online dashboard and data analysis approach for assessing COVID-19 case and death data. F1000Research, 2020. 9.
https://doi.org/10.12688/f1000research.24164.1
Sohrabi, C. and Z. Alsafi, O′ Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 2020.
https://doi.org/10.1016/j.ijsu.2020.02.034
Chaimayo, C., et al., Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand. Virology journal, 2020. 17(1): p. 1-7.
https://doi.org/10.1186/s12985-020-01452-5
Tang, Y.-W., et al., Laboratory diagnosis of COVID-19: current issues and challenges. Journal of clinical microbiology, 2020. 58(6): p. e00512-20.
https://doi.org/10.1128/JCM.00512-20
van Kasteren, P.B., et al., Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. Journal of Clinical Virology, 2020. 128: p. 104412.
https://doi.org/10.1016/j.jcv.2020.104412
Graham, T.G., et al., Open-source RNA extraction and RT-qPCR methods for SARS-CoV-2 detection. PloS one, 2021. 16(2): p. e0246647.
https://doi.org/10.1371/journal.pone.0246647
Randazzo, W., et al., SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water research, 2020. 181: p. 115942.
https://doi.org/10.1016/j.watres.2020.115942
Mak, G.C., et al., Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. Journal of Clinical Virology, 2020. 129: p. 104500.
https://doi.org/10.1016/j.jcv.2020.104500
Lambert-Niclot, S., et al., Evaluation of a rapid diagnostic assay for detection of SARS-CoV-2 antigen in nasopharyngeal swabs. Journal of clinical microbiology, 2020. 58(8): p. e00977-20.
https://doi.org/10.1128/JCM.00977-20
Zou, L., et al., SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England journal of medicine, 2020. 382(12): p. 1177-1179.
https://doi.org/10.1056/NEJMc2001737
Cattelan, A.M., et al., Rapid Antigen Test LumiraDxTM vs. Real Time Polymerase Chain Reaction for the Diagnosis of SARS-CoV-2 Infection: A Retrospective Cohort Study. International Journal of Environmental Research and Public Health, 2022. 19(7): p. 3826.
https://doi.org/10.3390/ijerph19073826
Vojtkovská, V., et al., Direct Detection of Feline Coronavirus by Three Rapid Antigen Immunochromatographic Tests and by Real-Time PCR in Cat Shelters. Veterinary Sciences, 2022. 9(2): p. 35.
https://doi.org/10.3390/vetsci9020035
Baldanti, F., et al., Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future. Critical Reviews in Clinical Laboratory Sciences, 2022: p. 1-15.
https://doi.org/10.1080/10408363.2022.2045250
Albert, E., et al., Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clinical Microbiology and Infection, 2021. 27(3): p. 472. e7-472. e10.
https://doi.org/10.1016/j.cmi.2020.11.004
Torres, I., et al., Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clinical Microbiology and Infection, 2021. 27(4): p. 636. e1-636. e4.
https://doi.org/10.1016/j.cmi.2020.12.022
Winkel, B., et al., Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study. BMJ open, 2021. 11(10): p. e048206.
https://doi.org/10.1136/bmjopen-2020-048206
Gremmels, H., et al., Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. EClinicalMedicine, 2021. 31: p. 100677.
https://doi.org/10.1016/j.eclinm.2020.100677
Treggiari, D., et al., SARS‐CoV‐2 rapid antigen test in comparison to RT‐PCR targeting different genes: A real‐life evaluation among unselected patients in a regional hospital of Italy. Journal of Medical Virology, 2022. 94(3): p. 1190-1195.
https://doi.org/10.1002/jmv.27378
Linares, M., et al., Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. Journal of Clinical Virology, 2020. 133: p. 104659.
https://doi.org/10.1016/j.jcv.2020.104659
Iqbal, B., et al., Comparison of SARS-CoV-2 antigen electrochemiluminescence immunoassay to RT-PCR assay for laboratory diagnosis of COVID-19 in Peshawar. Diagnosis, 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com